Differential presentation of hypersensitivity reactions to carboplatin and oxaliplatin: Phenotypes, endotypes, and management with desensitization

Successful administration of omalizumab by desensitization protocol following systemic reactions in 12 patients

(2021) Marta Bernaola et al.   Journal of Allergy and Clinical Immunology-In Practice

Use and Interpretation of Acute and Baseline Tryptase in Perioperative Hypersensitivity and Anaphylaxis

(2021) Joana Vitte et al.   Journal of Allergy and Clinical Immunology-In Practice

Usefulness of Omalizumab in Rapid Drug Desensitization in Patients with Severe Anaphylaxis Induced by Carboplatin: Open Questions

(2020) L Sánchez-Morillas et al.   JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY

Endophenotyping Oxaliplatin Hypersensitivity: Personalizing Desensitization to the Atypical Platin

(2020) Jared Silver et al.   Journal of Allergy and Clinical Immunology-In Practice

Rapid desensitization to antineoplastic drugs in an outpatient immunoallergology clinic

(2020) Joana Caiado et al.   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

Omalizumab and other biologics in drug desensitization

(2020) Javier Fernandez et al.   Current Opinion in Allergy and Clinical Immunology

Diagnosis and treatment of drug hypersensitivity reactions to biologicals: Medical algorithm

(2020) Barbara Carolyn Yang et al.   ALLERGY

Practical Guidelines for the Evaluation and Management of Drug Hypersensitivity: General Concepts

(2020) Ana Dioun Broyles et al.   Journal of Allergy and Clinical Immunology-In Practice

Interleukin‐6: A novel biomarker for monoclonal antibody and chemotherapy‐associated hypersensitivity confirms a cytokine release syndrome phenotype‐endotype association

(2020) Baruch D. Jakubovic et al.   ALLERGY

“Cytokine storm”, not only in COVID-19 patients. Mini-review

(2020) Norbert Lukan   IMMUNOLOGY LETTERS

Immune Pathomechanism and Classification of Drug Hypersensitivity

(2019) Werner J Pichler   ALLERGY

Hypersensitivity reactions to therapeutic monoclonal antibodies: Phenotypes and endotypes

(2018) Ghislaine Annie C. Isabwe et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Drug Hypersensitivity and Desensitizations: Mechanisms and New Approaches

(2017) Leticia de las Vecillas Sánchez et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Drug Hypersensitivity and Anaphylaxis in Cancer and Chronic Inflammatory Diseases: The Role of Desensitizations

(2017) Mariana Castells   Frontiers in Immunology

Safety, Costs, and Efficacy of Rapid Drug Desensitizations to Chemotherapy and Monoclonal Antibodies

(2016) David Sloane et al.   Journal of Allergy and Clinical Immunology-In Practice

Presentation and Diagnosis of Hypersensitivity to Platinum Drugs

(2015) Joana Caiado et al.   CURRENT ALLERGY AND ASTHMA REPORTS

Anaphylaxis to Chemotherapy and Monoclonal Antibodies

(2015) Mariana C. Castells   IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA

International Consensus on drug allergy

(2014) P. Demoly et al.   ALLERGY

Diagnostic Tools for Hypersensitivity to Platinum Drugs and Taxanes: Skin Testing, Specific IgE, and Mast Cell/Basophil Mediators

(2014) Joana Caiado et al.   CURRENT ALLERGY AND ASTHMA REPORTS

Master regulator of intestinal disease: IL-6 in chronic inflammation and cancer development

(2014) Maximilian J. Waldner et al.   SEMINARS IN IMMUNOLOGY

Deleterious BRCA1/2 mutation is an independent risk factor for carboplatin hypersensitivity reactions

(2013) D H Moon et al.   BRITISH JOURNAL OF CANCER

Carboplatin-, Oxaliplatin-, and Cisplatin–specific IgE: Cross-reactivity and Value in the Diagnosis of Carboplatin and Oxaliplatin Allergy

(2013) Joana Caiado et al.   Journal of Allergy and Clinical Immunology-In Practice

Oxaliplatin Hypersensitivity: Evaluation, Implications of Skin Testing, and Desensitization

(2013) Johnson T. Wong et al.   Journal of Allergy and Clinical Immunology-In Practice

Platinum Agent-Induced Hypersensitivity Reactions: Data Mining of the Public Version of the FDA Adverse Event Reporting System, AERS

(2012) Toshiyuki Sakaeda et al.   International Journal of Medical Sciences

Use of Omalizumab to Achieve Successful Desensitization After Oxaliplatin Anaphylaxis

(2012) K.N. Cahill et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Outcomes and safety of rapid desensitization for chemotherapy hypersensitivity

(2009) Ticha Limsuwan et al.   Expert Opinion On Drug Safety

Risk stratification for desensitization of patients with carboplatin hypersensitivity: Clinical presentation and management

(2009) Paul E. Hesterberg et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY